Module 3.2: Health Informatics Focus Areas

• healthcare-analytics 

· Module 3.2 Learning Resources 

Readings:

· Nelson, R., & Staggers, N. (2018). Health informatics: An interprofessional approach (2nd ed.). St. Louis, Missouri: Elsevier. 

o Chapter 21 Improving the User Experience for Health Information Technology

o Chapter 22 Informatics-related Standards and Standards-setting Organizations

o Chapter 23 Data Science and Analytics in Healthcare

o Chapter 24 Patient Safety and Quality Initiatives in Health Informatics

· McCarthy, K. (2014). Why interoperability is important for patient outcomes. Retrieved from: https://www.nuemd.com/news/2014/02/22/interoperability-important-patient-outcomes 

· Sweeney, J. (2017). Healthcare informatics. Retrieved from: http://www.himss.org/library/healthcare-informatics

· American Medical Informatics Association (AMIA.org)

· Berg, G. (2015). 3 Ways big data is improving healthcare analytics. Retrieved from: http://www.healthcareitnews.com/blog/3-ways-big-data-improving-healthcare-analytics 

Module 3.2 Activity 

This Learning Activity will help you t

This Learning Activity will help you to develop skills and knowledge that you will need for the Competency Assessments. It is highly recommended that you complete this optional activity.

Health Informatics Focus Area

The American Medical Informatics Association categorizes informatics into five areas:

2. Translational Bioinformatics

3. Clinical Research Informatics

4. Clinical Informatics

5. Consumer Health Informatics

6. Public Health Informatics

Choose two of the above areas and:

• Analyze (compare) two definitions for each focus area.
• Analyze the importance of each focus area in health care today.
• Identify and describe a hot topic related to each focus area.
• Describe a scholarly website for each focus area.

Include a minimum of four scholarly resources to support your statements.

Provide current creditable sources supporting your statements.

Prepare this paper according to current APA guidelines.

No plagiarism will be checked with turnitin.

APA style formatting, font 12, double spaced with headers. 

Will need Title page, content 2 – 3 paper in length, plus a minimum of 3 peered reviewed references in the Reference page. 

Chronic Disease Health Promotion and Maintenance/for adults age 35–65

Chronic Disease

Write a 2–3-page paper discussing the concepts of health promotion, health maintenance, health restoration and health teaching to an adult patient with this chronic disease (Rheumatoid Arthritis). Be sure to integrate Evidence Based Practice into your discussion.

Please use headings for: 

Health promotion

Health maintenance

Health restoration and education

ITS IMPORTANT TO MEET THE COMPETENCIES !

Write a 5–6-page article on a controversial topic related to pharmacology. Explain appropriate use of pharmacology; the relationship between quality patient outcomes, patient safety, and the use of pharmacology; and how the topic affects communities and organizations. Describe inequities regarding access to pharmacological treatments.

By successfully completing this assessment, you will demonstrate your proficiency in the following course competencies and assessment criteria:

• Competency 1: Apply practice guidelines and standards of evidence-based practice related to pharmacology for safe and effective nursing practice.       
  • (IMPORTANT) -Explain the appropriate use of pharmacology.
• Competency 2: Explain the relationship between quality patient outcomes, patient safety, and the appropriate use of pharmacology and psychopharmacology.       
  • (IMPORTANT) -Explain the relationship between quality patient outcomes, patient safety, and the use of pharmacology.
  • (IMPORTANT) -Explain how pharmacology affects communities and organizations.
• Competency 3: Apply the principles and practices of cultural competence with regard to pharmacological interventions.       
  • (IMPORTANT) -Describe inequities regarding access to pharmacology.
• Competency 4: Communicate in a manner that is scholarly, professional, and consistent with expectations of a nursing professional.       
  • (IMPORTANT) -Write content clearly and logically with correct use of grammar, punctuation, and mechanics.
  • Correctly format paper, citations, and references using current APA style.

Assessment Instructions 

In your professional nursing practice, you will likely encounter both patients and coworkers whose personal or cultural views on pharmacology may be quite different from your own. Understanding the most current research on pharmacological topics will help you make informed choices.

For this assessment, imagine your supervisor asks you to write an article on a controversial topic for the organization’s monthly newsletter in which you review the most recent research on the topic. She stresses you must present a balanced overview and equally address the pros and cons of the topic.

Preparation

Complete the following as you prepare to write your article:

1. Choose a topic from the list below:      
   • The use of medical marijuana.
   • The use of complementary and alternative medicines (CAM) versus traditional Western medicine.
   • Experimental drug programs and disease management.
   • Mandated vaccinations for children and the implications for parental choice not to vaccinate.
2. Search the Capella library and the Internet to locate peer-reviewed research articles on your selected topic. The information you use to support your work in this assessment must be as recent as possible.

Note: These are very broad topics. Limit your work to the scope of your practice and be mindful of the page-length requirements.

Requirements

Once you have identified your topic, organize your article as you wish. Be sure to include the following:

• Explain the appropriate use of the pharmacology related to the topic. Include elements such as diseases or health concerns associated with the topic and the efficacy and applicability of the pharmacology.
• Explain the relationship between quality patient outcomes, patient safety, and use of the pharmacology related to the topic. Remember to address both the benefits and limitations of the pharmacology in terms of specific diseases and populations.
• Explain how the topic affects both the community and the organization in terms of promoting health and wellness.
• Describe any inequities regarding access to the pharmacology related to the topic. Is access limited to specific groups or populations? Who determines access? On what is it based? Does access influence choice?

Follow APA guidelines to format this assessment. Include a title page and reference page.

Additional Requirements

• Number of pages: 5–6 (no more than 7).
• At least 4 current scholarly or professional resources.
• Times New Roman, 12 point, double-spaced font.

Respond to this post with a positive response :

Ask a probing question, substantiated with additional background information, evidence or research.

Share an insight from having read your colleagues’ postings, synthesizing the information to provide new perspectives.

Offer and support an alternative perspective using readings from the classroom or from your own research in the Walden Library.

Validate an idea with your own experience and additional research.

Make a suggestion based on additional evidence drawn from readings or after synthesizing multiple postings.

Expand on your colleagues’ postings by providing additional insights or contrasting perspectives based on readings and evidence.

Use at least 3 references

                                                   Main Post

The projected demands from an increasing elderly population on the nation’s healthcare system along with the accessibility and advancement of life-extending technology, has society begging the question of how we will meet the future demands of healthcare. According to Garza (2016), as reported by the World Health Organization (WHO) “the number of people aged 65 or older is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050,” (Garza, 2016, para. 1). This leaves society confronted with the issue of determining how to properly allocate the nations already limited healthcare resources to this future elderly population and still uphold appropriate ethical standards.  

Craig (2010), states that from an ethical standpoint, society must incorporate rights, merit, need, and priority of healthcare when assisting the geriatric population and appropriately allocating healthcare resources. Every person should have the right to equal access to healthcare, but in a system with already limited resources success rate of a necessary treatment should be evaluated and utilized based on what will produce the most effective outcomes, this is known as merit. Take for instance end-of-life dilemmas, as nurses we are bound by our ANA Code of Ethics and must respect our patient’s personal beliefs and values, but it is also the nurse’s responsibility to maintain educated and informed choices for both the patient and patient’s family. Ultimately, when planning for this growing population and determining such dilemmas as end-of-life care, it is imperative to ensure we are not only adding years to life, but life to years. Although, according to Crippen & Barnato (2011), healthcare costs are driven by the increases in managing chronic disease in this population and not necessarily with end-of-life spending. According to Garza (2016), by 2030, 60% of the generation will be managing more than one chronic condition. As frontline healthcare providers it is imperative to teach and promote preventative measures to chronic and costly diseases to help drive down the financial burden on healthcare systems in the long run. 

There will be a plethora of ethical challenges related to the preparation for the establishment of such a health care. One challenge will in determining the value of health. Who measures what is deemed healthy; the individual, the family, or the doctor? Will this determination of health discriminate against the elderly or those individuals with disabilities? Will the healthcare system discriminate against those who made bad lifestyle choices (i.e., smoking, drinking, obesity) to those with a certain genetic predisposition for a disorder? When we are sorting out all these ethical challenges, it is important to consider the economic impact on future generations of taxpayers if the policy is not changed. According to Crippen (2011), increased government spending on the elderly population is taking away from educational programs for the youth population and could also lead to an increase in chronic health issues at younger ages because there are no funds to provide them healthcare.

References

Barnett, J. E., & Quenzel, A. P. (2017). Innovating to meet the needs of our aging population.  Practice Innovations, 2(3), 136-149. http://dx.doi.org/10.1037/pri0000049

Craig, H. D. (2010). Caring enough to provide healthcare: An organizational framework for the ethical delivery of healthcare among aging patients. International Journal for Human Caring, 14(4), 27–30. Retrieved from https://eds-a-ebscohost            com.ezp.waldenulibrary.org/eds/pdfviewer/pdfviewer?vid=2&sid=0d6ab6aa-739e-4f50ab6c-4b5245f91690%40sdc-v-sessmgr01

Crippen, D., & Barnato, A. E. (2011). The ethical implications of health spending: Death and   other expensive conditions. Journal of Law, Medicine & Ethics, 39(2), 121–129.  https://doi.org/10.1111/j.1748-720X.2011.00582.x

Garza, A. (2016, January 19). The aging population: The increasing effects on health care. Pharmacy Times. Retrieved from https://www.pharmacytimes.com/publications/issue/2016/january2016/the-aging-population-the-increasing-effects-on-health-care

Hayutin, A.M., Dietz, M., Mitchell, L. (2010). New realities of an older America. Retrieved fromhttp://www.nasuad.org/sites/nasuad/files/hcbs/files/199/9941/New_Realities_of_an_Oldr_America.pdf

This patient is most likely to have plaque psoriasis, the most common form of psoriasis in young adults, with the average age of onset in the early twenties (Dunphy, Winland-Brown, Porter, & Thomas, 2015).)

            The risk factors for the development of psoriasis are family history. One-third of all patients with psoriasis have a relative with the disease, as in the case study above. When a parent is affected the children have a tendency for an early onset of the condition. Not only that but when both parents are affected the chance increases to forty-one percent of the children having the condition. This patient had an upper respiratory infection prior to the outbreak of the rash; this predisposes her for an outbreak of psoriasis. Even though there is a genetic disposition of the offspring of the parents having the disease, the exact genetic cause is unknown. Research is ongoing regarding the genetic and environmental influences on the cellular effects of the disease (Dunphy, Winland-Brown, Porter, & Thomas, 2015).

          The diagnostic tests to order for this patient are a CBC with differential and serum chemistry profile, serum uric acid level, antinuclear antibody titer, and rheumatoid factor. The serum uric acid level may be elevated. Diagnostic procedures are the Psoriasis Area and Severity Index, which evaluates overall severity and BSA involvement, and the Dermatology Life Quality Index. The top three differentials are seborrheic dermatitis, nummular eczema, and atopic dermatitis (Dominic, Bolder, & Golding, 2019)

            The goal of treatment for the condition of Psoriasis is to identify and avoid triggers. If the condition is mild to moderate keeping the skin hydrated with petrolatum ointments is helpful. Topical corticosteroids are also helpful initially in treating the disease and preventing skin atrophy. In the adult, initial therapy should be corticosteroids with varying potencies. These treatments should not be used longer than 4 weeks (Hendriks… et al, 2013).

            Follow-ups should be done to measure the body surface area involvement and to see if the therapy is working. If the therapy is not working alternative treatments should be prescribed or the addition of another agent to treat the condition should be done. If the psoriasis is greater than twenty percent of the body surface area, or severe extremity involvement especially of the hands and feet develops, a referral is needed (Menter, Gottlieb, Feldman, Van Voorhees, Leonardi, Gordon, et al…2008).

References

Domino, F., Baldor, R. A., & Golding, J. (2019). The 5-minute clinical consult. (27th

Ed.). [Mobile application software.] Retrieved from http://itunes.apple.com

Dunphy, L.M., Winland-Brown, J. E., Porter, B. O., & Thomas, D. J. (2015). Primary

care: the art and science of advanced practice nursing. (4th Ed.). Philadelphia, PA. F. A. Davis Company.

Hendriks, A. G., Keijsers, R. R., de Jong, e. M., Seyger, M. M., van de Kerkof, P. C.

(2013). Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 27(8) 931-951. doi:10.1111/jdv.12058

Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB,et al.

(2008). Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 58(5):826-50.